APA (7th ed.) Citation

NH, T., S, B., N, B., M, B., E, B., M, M., . . . F, F. (2025). Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis. Clinical and translational science, 18(5), e70245. https://doi.org/10.1111/cts.70245

Chicago Style (17th ed.) Citation

NH, Truong, et al. "Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis." Clinical and Translational Science 18, no. 5 (2025): e70245. https://doi.org/10.1111/cts.70245.

MLA (9th ed.) Citation

NH, Truong, et al. "Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis." Clinical and Translational Science, vol. 18, no. 5, 2025, p. e70245, https://doi.org/10.1111/cts.70245.